Fresenius SE & Co. KGaA - SIC # 9120 -

Ticker Exchange SIC # Website Latest Ticker
FSNUY Over the counter 9120 www.fresenius.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Fresenius SE & Co. KGaA

FMS or MASI: Which Is the Better Value Stock Right Now? - Jan 9th, 2026 9:40 am
Here's What's Concerning About Fresenius SE KGaA's (ETR:FRE) Returns On Capital - Dec 20th, 2025 1:15 am
Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature - Dec 18th, 2025 6:00 am
mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development - Dec 4th, 2025 1:00 am
North America Heart Pump Device Market Forecast and Company Analysis Report 2025-2033 Featuring Abbott, Getinge, Teleflex, Fresenius, LivaNova, CorWave, JARVIK HEART, ABIOMED - Nov 28th, 2025 2:04 am
Fresenius (XTRA:FRE): Does Recent Share Price Movement Reflect Its True Value? - Nov 28th, 2025 1:11 am
How Recent Developments Are Rewriting the Story for Fresenius SE KGaA - Nov 27th, 2025 1:07 pm
United States Home Healthcare Market Analysis Report 2025-2033 Featuring 3M Healthcare, Apple, Arkray, B. Braun Melsungen, BD And Co, F. Hoffmann-La Roche, Fresenius, and Hollister - Nov 26th, 2025 3:43 am
Fresenius (XTRA:FRE): How Does Its Current Valuation Stack Up After This Year's Strong Share Price Rally? - Nov 7th, 2025 3:13 am
Health Care Roundup: Market Talk - Nov 5th, 2025 3:11 pm
Fresenius SE & Co KGaA (FSNUF) Q3 2025 Earnings Call Highlights: Strong Core EPS Growth and ... - Nov 5th, 2025 2:04 pm
Fresenius: Q3 Earnings Snapshot - Nov 4th, 2025 6:02 am
Home Healthcare Market Prospects, Opportunities and Competitive Strategies (2025-2033) Featuring 3M Healthcare, Apple, Arkray, Braun, BD, Roche, Fresenius, and Hollister - Nov 3rd, 2025 5:34 am
FDA Grants Interchangeable Designation to Fresenius Kabi’s Biosimilars Conexxence® and Bomyntra® (denosumab-bnht) - Oct 29th, 2025 1:56 pm
Is Fresenius SE & Co. KGaA (ETR:FRE) Trading At A 49% Discount? - Oct 28th, 2025 4:52 am
Home Healthcare Market Research Report 2025-2030: Leading Companies are Innovating and Introducing New Home Healthcare Products to Gain a Competitive Advantage - Oct 21st, 2025 3:22 am
Here's Why Fresenius (FMS) is a Strong Value Stock - Oct 16th, 2025 7:40 am
Fresenius SE & Co. KGaA (ETR:FRE) is largely controlled by institutional shareholders who own 39% of the company - Oct 8th, 2025 10:44 pm
FMS vs. OFIX: Which Stock Is the Better Value Option? - Oct 7th, 2025 9:40 am
Why Fresenius (FMS) is a Top Momentum Stock for the Long-Term - Oct 2nd, 2025 7:50 am